Archive for the ‘Global Health’ category

BURDEN OF NTDs in SOUTH ASIA AND INDIA

January 5th, 2012

By: Vino Sundaram, MPH Candidate, Case Western Reserve University

India and Southeast Asia is of great interest to me due to my Indian decent.  My trips to India have shown me first hand how NTD’s have severely impacted rural, impoverished areas of India…it’s truly a heartbreaking sight.  As a public health student, I have a strong interest in socioeconomics and health outcomes on a global level.  Anyone who studies this field knows that it has been long established that poor socioeconomic status leads to increased rates of several diseases, with NTD’s among that list.  However, recently I came across a published article discussing the increasing burden of NTD’s in South Asia and India despite an a 7% economic growth in 2010.  As you can imagine, my eyebrows went “huh?”

The article went into great detail about the increasing number of cases in this region and an analysis of each individual disease.  South Asian countries make up one-fourth of all soil-transmitted helminth infections (the largest number being in India), at least one-third of global rabies deaths, and at least half of the global cases of lymphatic filariasis, visceral leishmaniasis, and leprosy.  Soil-transmitted helminth diseases have a large impact on children who are school-age with schoolteachers being the most responsible for administering meds to the affected children.  Often, children with this disease are unable to attend school or be productive workers for their families. (Note: In impoverished areas of India, the children often are pulled from school so that they can work to bring in income for a struggling family.  In turn, diseases that impact children and teenagers have a huge impact on the socioeconomic status of a household.)  Lymphatic filariasis has a large impact on worker productivity…India loses $1 billion dollars a year due to lymphatic filariasis.  Visceral leishmaniasis (VL) has had a similar effect on the region.  Because of the high price of treatments, families are forced to spend most of their income on treatments.  Therefore, there is a propagation of poverty that takes place due to this illness.  Also, similarly to lymphatic filariasis, it affects children and worker productivity.

It appears that the authors of the article suggest that there needs to be better management of NTD programs, specifically in this region of the world.  I definitely agree.  It is important to have management that involves people that are from the community being affected.  South Asia and India are regions that have gotten a great deal of attention from outside sources for their severe disease prevalence and incidence.  However, unfortunately, that same attention is not received from sources within the region.  In my opinion, this is a big part of the problem.  Governments, organizations, and medical facilities need to understand and realize how critical these diseases are.  This is not to downplay what has already been done, because there has been a lot of improvement.   Great efforts have been made to decrease incidence of these cases with a good amount of success. However much more work needs to be done.  Funding is critical; however, management and sustainability of programs is just as important.  It is also important to have the people of the community involved with their own preventative measures.  From a policy standpoint, the governments in these regions need to recognize the severity of their NTD problems.  If there is not involvement and support from the government, then economic improvements will not trickle down to health outcomes.  The non-profit organizations involved in NTD prevention need to be running at optimal efficiency so that funding and cases of disease are handled properly.  South Asia and India are facing a major disconnect between economic growth and conquering of NTD’s.  It will take more involvement from the government and from the people themselves in order to eventually eradicate these diseases.

As an Indian, I know that the region has so much potential to contribute great things to the world.  However, if the region itself does not help its own people to fight illness, then they will never help India and neighboring countries fulfill that potential.

Foreign Aid Is Not a Rathole

December 1st, 2011

Photo credit: Google Images

On this World AIDS Day, Dr. Ezekiel Emanuel, a special adviser at the White House Office of Management and Budget, contributes an op-ed to The New York Times. Dr. Emanuel discusses the progress we’ve made using foreign aid in the fight against HIV/AIDS, along with urging the need for more attention and efforts dedicated to addressing neglected tropical diseases. Check out the excerpt below, or click here to read the full op-ed on The New York Times:

“Many Americans feel that foreign assistance is like money poured down a rathole. The United States contributes more money every year — spending nearly a third of all global health aid — while tangible results in developing countries can be hard to see.

But the “rathole” argument is dead wrong. Indeed, this World AIDS Day, Dec. 1, provides a perfect opportunity to assess the results of our global health assistance efforts and to recognize the tremendous amount we have accomplished.”

 

 

The Neglected NTDs

November 14th, 2011

By: Alanna Shaikh

The public discourse around the neglected tropical diseases focuses almost entirely on the developing world. We talk about the NTD belt in Africa, helminthes in Asia, Chagas in Latin America. We hardly ever, though, think about at the NTDs in the wealthy world. What do they look like, then, in the places we don’t expect them? According to Peter Hotez and Meredith Gurwith, not great. In a July 2011 article published in the Public Library of Science, they look at Europe’s NTD burden, and the results are frustrating but illuminating.

It’s an interesting view on our new world of wealth distribution. We’re moving away from rich and poor countries. What we have, instead, are rich and poor communities. And the poor communities of Europe, just like the poor communities of Africa – or the United States – are afflicted with neglected tropical diseases. They are truly diseases of poverty and not geography. More than 20 percent of the population of Europe – 165 million people – lives below poverty thresholds, and that’s where you find the NTDs.

Eastern Europe and Turkey bear the biggest helminth burden, high enough to cause concerns about cognitive development among children. This stems from several causes. They’re the poorest countries in Europe, and they’ve faced the most hardship. The Balkans lost ground on health care during the extensive regional conflict, and the former Soviet bloc countries suffered as they tried to develop health structures without the leadership and financial support of Moscow. » Read more: The Neglected NTDs

The Case for a Global NTD Initiative

October 21st, 2011

As the 2011 World Health Summit approaches next week, the Global Network’s Managing Director Dr. Neeraj Mistry contributes another blogpost to the ONE Campaign Germany. Find the English version below:

By Dr. Neeraj Mistry, Managing Director, Global Network for Neglected Tropical Diseases

In my previous blog post, I identified neglected tropical diseases (NTDs) as some of the most common yet widely unrecognized diseases currently in the global health arena. NTDs have debilitating effects–impairing the health, economic development and education of the world’s poorest people, also known as the “bottom billion.” We call them neglected diseases because the 1.4 billion people who suffer from NTDs are often far from the houses and minds of people living in the developed world. It’s not all bad news, though. Not only are many of these diseases entirely treatable and preventable, but there have already been significant steps taken towards the control and elimination of NTDs.

Through the remarkable commitment of the United States, the United Kingdom and members of the G8, we have seen enormous gains in the treatment and prevention of NTDs around the world. The U.S. government’s commitment to eliminating NTDs has rapidly expanded in recent years. Through the establishment of USAID’s NTD program, the U.S. created a unique and extremely cost-effective public-private partnership that successfully facilitated the first large-scale efforts to integrate existing disease-specific treatment programs. Since its launch in 2006, the USAID NTD program, in partnership with the pharmaceutical industry, has expanded to countries across Africa, Asia and the Americas–improving the lives of more than 168 million people by delivering approximately 387 million NTD treatments, and training more than 200,000 community workers. » Read more: The Case for a Global NTD Initiative